Actively Recruiting

Age: 18Years - 99Years
All Genders
Healthy Volunteers
ID04877977

Long-term Observation of Participants With Mood Disorders

Led by National Institute of Mental Health (NIMH) · Updated on 2025-11-28

1000

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are following up with adults who previously participated in studies on mood disorders such as depression, bipolar disorder, and suicide risk at the National Institute of Mental Health. This research aims to understand the long-term effects of these conditions and the ongoing treatments participants may be receiving. They plan to identify factors that predict long-term depression, suicide attempts, and ketamine use. The study is conducted entirely remotely in two phases: an online phase and a telephone phase. In Phase 1, participants complete online surveys about their current mental health symptoms and treatments, taking about 30 minutes. Those interested may proceed to Phase 2, which involves a 1 to 4 hour phone interview covering detailed questions about mood, treatments, and medication use since leaving previous NIH studies. Participants provide information through surveys and phone interviews, with the option to skip any questions. Researchers will link this data with existing clinical and biological records collected over the past 20 years. The main outcome measured is the score on the Beck Depression Inventory. Secondary outcomes include self-reported suicide attempts, ketamine use, and suicide deaths identified from national data. Participation lasts about 20 minutes to 4 hours in total, with no in-person visits required.

CONDITIONS

Brief Title

Long-term Observation of Participants With Mood Disorders

Who Can Participate

Age: 18Years - 99Years
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • Participants who signed consent for Protocol 01-M-0254: The Evaluation of Patients with Mood and Anxiety Disorders and Healthy Volunteers over a year ago
  • Age 18 years or older
  • Able to provide informed consent online using study website or over the telephone
  • Able to read and write English
Not Eligible

You will not qualify if you...

  • None

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 screening and enrollment visit (online or telephone)

Long-term Monitoring

Duration - 1 year

Participants complete online or telephone assessments of current symptoms and are observed for long-term outcomes related to mood disorders, including depressive symptoms, suicide attempts, and ketamine use.

Periodic online or telephone assessments during the year

Trial Site Locations

Total: 1 location

1

National Institutes of Health Clinical Center

Bethesda, Maryland, United States, 20892

Actively Recruiting

Loading map...

Research Team

E

Elizabeth D Ballard, Ph.D.

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Similar Trials

The Effects of Citalopram on the Brain's Response to Emotion...

Emotional Processing

Actively Recruiting

1 location

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Published Research Related To This Trial

Nocturnal Wakefulness Is Associated With Next-Day Suicidal Ideation in Major Depressive Disorder and Bipolar Disorder.

Elizabeth D Ballard, Jennifer L Vande Voort, Rebecca A Bernert...

https://pubmed.ncbi.nlm.nih.gov/27337418